Immunosuppressant drugs in the treatment of allergic eye disease: do they have potential usage?
Author:
- 7 November 2003
- journal article
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 33 (11) , 1479-1480
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Effect of FK506 eye drops on late and delayed‐type responses in ocular allergy modelsClinical & Experimental Allergy, 2003
- Allergic and immunologic disorders of the eye. Part II: Ocular allergyJournal of Allergy and Clinical Immunology, 2000
- Allergic eye disease – a clinical challengeClinical & Experimental Allergy, 1998
- More data reported for HDL's role in heart diseaseThe Lancet, 1998
- Tacrolimus of benefit in atopic dermatitisThe Lancet, 1998
- The mechanism of action of cyclosporin A and FK506Immunology Today, 1992
- Topical Cyclosporine in Vernal KeratoconjunctivitisOphthalmology, 1991
- Topical Use of Cyclosporine in the Treatment of Vernal KeratoconjunctivitisAmerican Journal of Ophthalmology, 1990
- FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.The Journal of Antibiotics, 1987